{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:27:32Z","timestamp":1793784452684,"version":"4.6.1"},"reference-count":132,"publisher":"IMR Press","issue":"7","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Dilated cardiomyopathy (DCM) is one of the most common cardiomyopathy phenotypes. Moreover, sudden cardiac death (SCD) remains a leading cause of mortality in patients with DCM, predominantly driven by malignant ventricular arrhythmias (VAs). Current guideline-recommended risk stratification relies heavily on left ventricular ejection fraction (LVEF) to guide implantable cardioverter-defibrillator (ICD) therapy; however, attention has recently shifted toward a multiparametric strategy that integrates clinical characteristics with electrocardiographic markers, biomarkers, cardiac magnetic resonance (CMR) findings, genetic testing, and electrophysiological studies. This review summarizes current evidence on established and emerging tools for SCD risk stratification in DCM, highlights the limitations of single-parameter approaches, and discusses future directions toward more personalized, dynamic risk assessment to optimize SCD outcomes.<\/jats:p>","DOI":"10.31083\/rcm49889","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:31:43Z","timestamp":1785407503000},"source":"Crossref","is-referenced-by-count":1,"title":["Redefining Sudden Cardiac Death Risk Stratification in Dilated Cardiomyopathy: An Integrative Approach"],"prefix":"10.31083","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9153-5697","authenticated-orcid":true,"given":"Aikaterini-Eleftheria","family":"Karanikola","sequence":"first","affiliation":[{"name":"First Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2184-3296","authenticated-orcid":true,"given":"Ioannis","family":"Doundoulakis","sequence":"additional","affiliation":[{"name":"First Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4861-2404","authenticated-orcid":true,"given":"Christos-Konstantinos","family":"Antoniou","sequence":"additional","affiliation":[{"name":"First Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5608-4900","authenticated-orcid":true,"given":"Panagiotis","family":"Alexandrou","sequence":"additional","affiliation":[{"name":"First Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8204-7495","authenticated-orcid":true,"given":"Christos","family":"Vosikas","sequence":"additional","affiliation":[{"name":"First Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-5101","authenticated-orcid":true,"given":"Georgios","family":"Leventopoulos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4093-4601","authenticated-orcid":true,"given":"Athanasios","family":"Kordalis","sequence":"additional","affiliation":[{"name":"First Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4531-9712","authenticated-orcid":true,"given":"Dimitrios","family":"Tsiachris","sequence":"additional","affiliation":[{"name":"First Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-6725","authenticated-orcid":true,"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[{"name":"First Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6628-0303","authenticated-orcid":true,"given":"Konstantinos","family":"Gatzoulis","sequence":"additional","affiliation":[{"name":"First Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, B\u00f6hm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. European Heart Journal. 2016; 37: 1850\u20131858.","DOI":"10.1093\/eurheartj\/ehv727"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"McKenna WJ, Maron BJ, Thiene G. Classification, Epidemiology, and Global Burden of Cardiomyopathies. Circulation Research. 2017; 121: 722\u2013730.","DOI":"10.1161\/CIRCRESAHA.117.309711"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Akhtar M, Elliott PM. Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy. Current Cardiology Reports. 2019; 21: 155.","DOI":"10.1007\/s11886-019-1236-3"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. The New England Journal of Medicine. 2004; 350: 2151\u20132158.","DOI":"10.1056\/NEJMoa033088"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"K\u00f8ber L, Thune JJ, Nielsen JC, Haarbo J, Videb\u00e6k L, Korup E, et al. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. The New England Journal of Medicine. 2016; 375: 1221\u20131230.","DOI":"10.1056\/NEJMoa1608029"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal. 2022; 43: 3997\u20134126.","DOI":"10.1093\/eurheartj\/ehac262"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Gentile P, Merlo M, Cannat\u00e0 A, Gobbo M, Artico J, Stolfo D, et al. Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History. Journal of the American Heart Association. 2019; 8: e010705.","DOI":"10.1161\/JAHA.118.010705"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Gatzoulis KA, Sideris A, Kanoupakis E, Sideris S, Nikolaou N, Antoniou CK, et al. Arrhythmic risk stratification in heart failure: Time for the next step? Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc. 2017; 22: e12430.","DOI":"10.1111\/anec.12430"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Halliday BP, Cleland JGF, Goldberger JJ, Prasad SK. Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future. Circulation. 2017; 136: 215\u2013231.","DOI":"10.1161\/CIRCULATIONAHA.116.027134"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Centuri\u00f3n OA, Alderete JF, Torales JM, Garc\u00eda LB, Scavenius KE, Mi\u00f1o LM. Myocardial Fibrosis as a Pathway of Prediction of Ventricular Arrhythmias and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy. Critical Pathways in Cardiology. 2019; 18: 89\u201397.","DOI":"10.1097\/HPC.0000000000000171"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Disertori M, Mas\u00e8 M, Ravelli F. Myocardial fibrosis predicts ventricular tachyarrhythmias. Trends in Cardiovascular Medicine. 2017; 27: 363\u2013372.","DOI":"10.1016\/j.tcm.2017.01.011"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Tzimas C, Johnson DM, Santiago DJ, Vafiadaki E, Arvanitis DA, Davos CH, et al. Impaired calcium homeostasis is associated with sudden cardiac death and arrhythmias in a genetic equivalent mouse model of the human HRC-Ser96Ala variant. Cardiovascular Research. 2017; 113: 1403\u20131417.","DOI":"10.1093\/cvr\/cvx113"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Jiang X, Xu Y, Sun J, Wang L, Guo X, Chen Y. The phenotypic characteristic observed by cardiac magnetic resonance in a PLN-R14del family. Scientific Reports. 2020; 10: 16478.","DOI":"10.1038\/s41598-020-73359-8"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Chaumont C, Suffee N, Gandjbakhch E, Balse E, Anselme F, Hatem SN. Epicardial origin of cardiac arrhythmias: clinical evidences and pathophysiology. Cardiovascular Research. 2022; 118: 1693\u20131702.","DOI":"10.1093\/cvr\/cvab213"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Kotake Y, Nalliah CJ, Campbell T, Bennett RG, Turnbull S, Kumar S. Comparison of the arrhythmogenic substrate for ventricular tachycardia in patients with ischemic vs non-ischemic cardiomyopathy - insights from high-density, multi-electrode catheter mapping. Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing. 2023; 66: 5\u201314.","DOI":"10.1007\/s10840-021-01088-7"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Sani MM, Sung E, Engels M, Daimee UA, Trayanova N, Wu KC, et al. Association of epicardial and intramyocardial fat with ventricular arrhythmias. Heart Rhythm. 2023; 20: 1699\u20131705.","DOI":"10.1016\/j.hrthm.2023.08.033"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Mahmoud B, Cox MGPJ, de Brouwer R, van der Heide MYC, Gorter TM, Meems LMG, et al. Epicardial adipose tissue and malignant ventricular arrhythmias in phospholamban p.(Arg14del) variant carriers. European Heart Journal. 2025; 46: 1766\u20131768.","DOI":"10.1093\/eurheartj\/ehaf118"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Ernault AC, Meijborg VMF, Coronel R. Modulation of Cardiac Arrhythmogenesis by Epicardial Adipose Tissue: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2021; 78: 1730\u20131745.","DOI":"10.1016\/j.jacc.2021.08.037"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Meng L, Shivkumar K, Ajijola O. Autonomic Regulation and Ventricular Arrhythmias. Current Treatment Options in Cardiovascular Medicine. 2018; 20: 38.","DOI":"10.1007\/s11936-018-0633-z"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Palacios M, Friedrich H, G\u00f6tze C, Vallverd\u00fa M, de Luna AB, Caminal P, et al. Changes of autonomic information flow due to idiopathic dilated cardiomyopathy. Physiological Measurement. 2007; 28: 677\u2013688.","DOI":"10.1088\/0967-3334\/28\/6\/006"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Parthenakis FI, Prassopoulos VK, Koukouraki SI, Zacharis EA, Diakakis GF, Karkavitsas NK, et al. Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: relationship to regional wall motion and myocardial perfusion abnormalities. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 2002; 9: 15\u201322.","DOI":"10.1067\/mnc.2002.118239"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Dajani AHJ, Liu MB, Olaopa MA, Cao L, Valenzuela-Ripoll C, Davis TJ, et al. Heterogeneous cardiac sympathetic innervation gradients promote arrhythmogenesis in murine dilated cardiomyopathy. JCI Insight. 2023; 8: e157956.","DOI":"10.1172\/jci.insight.157956"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC Guidelines for the management of cardiomyopathies. European Heart Journal. 2023; 44: 3503\u20133626.","DOI":"10.1093\/eurheartj\/ehad194"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA\/ACC\/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018; 138: e272\u2013e391.","DOI":"10.1161\/CIR.0000000000000549"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Milaras N, Dourvas P, Doundoulakis I, Sotiriou Z, Nevras V, Xintarakou A, et al. Noninvasive electrocardiographic risk factors for sudden cardiac death in dilated ca rdiomyopathy: is ambulatory electrocardiography still relevant? Heart Failure Reviews. 2023; 28: 865\u2013878.","DOI":"10.1007\/s10741-023-10300-x"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Lee WC, Watanabe M, Yokoshiki H, Temma T, Kamada R, Takahashi M, et al. Rapid-rate nonsustained ventricular tachycardias in high-risk dilated cardiomyopathy patients. Pacing and Clinical Electrophysiology : PACE. 2020; 43: 1086\u20131095.","DOI":"10.1111\/pace.14027"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Setti M, Merlo M, Gigli M, Munaretto L, Paldino A, Stolfo D, et al. Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy. European Journal of Heart Failure. 2024; 26: 581\u2013589.","DOI":"10.1002\/ejhf.3168"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Boas R, Thune JJ, Pehrson S, K\u00f8ber L, Nielsen JC, Videb\u00e6k L, et al. Prevalence and prognostic association of ventricular arrhythmia in non-ischaemic heart failure patients: results from the DANISH trial. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 2021; 23: 587\u2013595.","DOI":"10.1093\/europace\/euaa341"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Venner MFGHM, Heymans ABM, Beelen NJ, Stroeks SLVM, Faassen IME, Sikking MA, et al. Predictive value of ambulatory ECG monitoring for malignant arrhythmic events in genetic dilated cardiomyopathy. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 2025; 27: euaf279.","DOI":"10.1093\/europace\/euaf279"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Gatzoulis KA, Arsenos P, Trachanas K, Dilaveris P, Antoniou C, Tsiachris D, et al. Signal-averaged electrocardiography: Past, present, and future. Journal of Arrhythmia. 2018; 34: 222\u2013229.","DOI":"10.1002\/joa3.12062"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Goedel-Meinen L, Hofmann M, Ryba S, Sch\u00f6mig A. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic dilated cardiomyopathy. The American Journal of Cardiology. 2001; 87: 809\u2013812, A9.","DOI":"10.1016\/s0002-9149(00)01514-9"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Fauchier L, Babuty D, Cosnay P, Poret P, Rouesnel P, Fauchier JP. Long-term prognostic value of time domain analysis of signal-averaged electrocardiography in idiopathic dilated cardiomyopathy. The American Journal of Cardiology. 2000; 85: 618\u2013623.","DOI":"10.1016\/s0002-9149(99)00821-8"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Mancini DM, Wong KL, Simson MB. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation. 1993; 87: 1083\u20131092.","DOI":"10.1161\/01.cir.87.4.1083"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Brembilla-Perrot B, Terrier de la Chaise A, Jacquemin L, Beurrier D, Houplon P. The signal-averaged electrocardiogram is of limited value in patients with bundle branch block and dilated cardiomyopathy in predicting inducible ventricular tachycardia or death. The American Journal of Cardiology. 1997; 79: 154\u2013159.","DOI":"10.1016\/s0002-9149(96)00703-5"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Grimm W, Hoffmann J, Knop U, Winzenburg J, Menz V, Maisch B. Value of time- and frequency-domain analysis of signal-averaged electrocardiography for arrhythmia risk prediction in idiopathic dilated cardiomyopathy. Pacing and Clinical Electrophysiology : PACE. 1996; 19: 1923\u20131927.","DOI":"10.1111\/j.1540-8159.1996.tb03254.x"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Fei L, Goldman JH, Prasad K, Keeling PJ, Reardon K, Camm AJ, et al. QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. European Heart Journal. 1996; 17: 258\u2013263.","DOI":"10.1093\/oxfordjournals.eurheartj.a014843"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Fauchier L, Douglas J, Babuty D, Cosnay P, Fauchier JP. QT dispersion in nonischemic dilated cardiomyopathy. A long-term evaluation. European Journal of Heart Failure. 2005; 7: 277\u2013282.","DOI":"10.1016\/j.ejheart.2004.07.009"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Arsenos P, Gatzoulis KA, Dilaveris P, Gialernios T, Sideris S, Lazaros G, et al. The rate-corrected QT interval calculated from 24-hour Holter recordings may serve as a significant arrhythmia risk stratifier in heart failure patients. International Journal of Cardiology. 2011; 147: 321\u2013323.","DOI":"10.1016\/j.ijcard.2010.12.076"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Chen S, Motonaga KS, Hollander SA, Almond CS, Rosenthal DN, Kaufman BD, et al. Electrocardiographic repolarization abnormalities and increased risk of life-threatening arrhythmias in children with dilated cardiomyopathy. Heart Rhythm. 2016; 13: 1289\u20131296.","DOI":"10.1016\/j.hrthm.2016.02.014"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Galinier M, Vialette JC, Fourcade J, Cabrol P, Dongay B, Massabuau P, et al. QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Importance of aetiology. European Heart Journal. 1998; 19: 1054\u20131062.","DOI":"10.1053\/euhj.1997.0865"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Sakabe K, Ikeda T, Sakata T, Kawase A, Kumagai K, Tezuka N, et al. Comparison of T-wave alternans and QT interval dispersion to predict ventricular tachyarrhythmia in patients with dilated cardiomyopathy and without antiarrhythmic drugs: a prospective study. Japanese Heart Journal. 2001; 42: 451\u2013457.","DOI":"10.1536\/jhj.42.451"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RFE, Tritto M, Sallusti L, et al. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. Journal of the American College of Cardiology. 2007; 50: 1896\u20131904.","DOI":"10.1016\/j.jacc.2007.09.004"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Grimm W, Christ M, Bach J, M\u00fcller HH, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation. 2003; 108: 2883\u20132891.","DOI":"10.1161\/01.CIR.0000100721.52503.85"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Goldberger JJ, Suba\u010dius H, Patel T, Cunnane R, Kadish AH. Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. Journal of the American College of Cardiology. 2014; 63: 1879\u20131889.","DOI":"10.1016\/j.jacc.2013.12.021"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Rashba EJ, Estes NAM, Wang P, Schaechter A, Howard A, Zareba W, et al. Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial. Heart Rhythm. 2006; 3: 281\u2013286.","DOI":"10.1016\/j.hrthm.2005.11.028"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Karcz M, Chojnowska L, Zareba W, Ruzy\u0142\u0142o W. Prognostic significance of heart rate variability in dilated cardiomyopathy. International Journal of Cardiology. 2003; 87: 75\u201381.","DOI":"10.1016\/s0167-5273(02)00207-3"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Grimm W, Schmidt G, Maisch B, Sharkova J, M\u00fcller HH, Christ M. Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. Journal of Cardiovascular Electrophysiology. 2003; 14: 819\u2013824.","DOI":"10.1046\/j.1540-8167.2003.03085.x"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Klingenheben T, Ptaszynski P, Hohnloser SH. Heart rate turbulence and other autonomic risk markers for arrhythmia risk stratification in dilated cardiomyopathy. Journal of Electrocardiology. 2008; 41: 306\u2013311.","DOI":"10.1016\/j.jelectrocard.2007.10.004"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Demming T, Sandrock S, Kuhn C, Kotzott L, Tahmaz N, Bonnemeier H. Deceleration capacity: A novel predictor for total mortality in patients with non-ischemic dilated cardiomyopathy. International Journal of Cardiology. 2016; 221: 289\u2013293.","DOI":"10.1016\/j.ijcard.2016.06.205"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Yang Y, Wang F, Zou C, Dong H, Huang X, Zhou B, et al. Male Patients With Dilated Cardiomyopathy Exhibiting a Higher Heart Rate Acceleration Capacity or a Lower Deceleration Capacity Are at Higher Risk of Cardiac Death. Frontiers in Physiology. 2018; 9: 1774.","DOI":"10.3389\/fphys.2018.01774"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Hershberger RE, Givertz MM, Ho CY, Judge DP, Kantor PF, McBride KL, et al. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine : Official Journal of the American College of Medical Genetics. 2018; 20: 899\u2013909.","DOI":"10.1038\/s41436-018-0039-z"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Eldemire R, Mestroni L, Taylor MRG. Genetics of Dilated Cardiomyopathy. Annual Review of Medicine. 2024; 75: 417\u2013426.","DOI":"10.1146\/annurev-med-052422-020535"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Anastasiou V, Papazoglou AS, Gossios T, Zegkos T, Daios S, Moysidis DV, et al. Prognostic implications of genotype findings in non-ischaemic dilated cardiomyopathy: A network meta-analysis. European Journal of Heart Failure. 2024; 26: 2155\u20132168.","DOI":"10.1002\/ejhf.3403"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Gigli M, Merlo M, Graw SL, Barbati G, Rowland TJ, Slavov DB, et al. Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy. Journal of the American College of Cardiology. 2019; 74: 1480\u20131490.","DOI":"10.1016\/j.jacc.2019.06.072"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Gigli M, Stolfo D, Graw SL, Merlo M, Gregorio C, Nee Chen S, et al. Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants. Circulation. 2021; 144: 1600\u20131611.","DOI":"10.1161\/CIRCULATIONAHA.121.053521"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Becker MA, Cornel JH, Van de Ven PM, van Rossum AC, Allaart CP, Germans T. The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis. JACC: Cardiovascular Imaging. 2018; 11: 1274\u20131284.","DOI":"10.1016\/j.jcmg.2018.03.006"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Di Marco A, Anguera I, Schmitt M, Klem I, Neilan TG, White JA, et al. Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis. JACC: Heart Failure. 2017; 5: 28\u201338.","DOI":"10.1016\/j.jchf.2016.09.017"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Zhang B, Liu Z, Farooq S, Du M, Lu P, Yang Y, et al. CMR-LGE imaging features of dilated cardiomyopathy and relationship with left ventricular function. Scientific Reports. 2025; 15: 43696.","DOI":"10.1038\/s41598-025-27411-0"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Kariki O, Antoniou CK, Mavrogeni S, Gatzoulis KA. Updating the Risk Stratification for Sudden Cardiac Death in Cardiomyopathies: The Evolving Role of Cardiac Magnetic Resonance Imaging. An Approach for the Electrophysiologist. Diagnostics (Basel, Switzerland). 2020; 10: 541.","DOI":"10.3390\/diagnostics10080541"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Zhou D, Zhang H, Yang W, Wang Y, Zhu L, Jiang M, et al. Risk Stratification of Sudden Cardiac Death in Nonischemic Dilated Cardiomyopathy: Arrhythmogenic Substrate Assessment in Cardiac MRI. Radiology. 2025; 316: e243427.","DOI":"10.1148\/radiol.243427"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Zhou D, Zhu L, Li S, Wu W, Zhuang B, Xu J, et al. Prognosis and Risk Stratification in Dilated Cardiomyopathy With LVEF\u226435%: Cardiac MRI Insights for Better Outcomes. Circulation. Cardiovascular Imaging. 2025; 18: e017246.","DOI":"10.1161\/CIRCIMAGING.124.017246"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Perone F, Dentamaro I, La Mura L, Alifragki A, Marketou M, Cavarretta E, et al. Current Insights and Novel Cardiovascular Magnetic Resonance-Based Techniques in the Prognosis of Non-Ischemic Dilated Cardiomyopathy. Journal of Clinical Medicine. 2024; 13: 1017.","DOI":"10.3390\/jcm13041017"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Di Bella G, Micari A, Licordari R, Crea P, Colarusso L, Cusm\u00e0-Piccione M, et al. Cardiac Magnetic Resonance Imaging and Arrhythmic Risk Stratification in Cardiomyopathies. Journal of Clinical Medicine. 2025; 14: 4922.","DOI":"10.3390\/jcm14144922"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Chen W, Qian W, Zhang X, Li D, Qian Z, Xu H, et al. Ring-like late gadolinium enhancement for predicting ventricular tachyarrhythmias in non-ischaemic dilated cardiomyopathy. European Heart Journal. Cardiovascular Imaging. 2021; 22: 1130\u20131138.","DOI":"10.1093\/ehjci\/jeab117"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Halliday BP, Gulati A, Ali A, Guha K, Newsome S, Arzanauskaite M, et al. Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction. Circulation. 2017; 135: 2106\u20132115.","DOI":"10.1161\/CIRCULATIONAHA.116.026910"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"de Frutos F, Ochoa JP, Fern\u00e1ndez AI, Gallego-Delgado M, Navarro-Pe\u00f1alver M, Casas G, et al. Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype-phenotype correlation. European Heart Journal. Cardiovascular Imaging. 2023; 25: 75\u201385.","DOI":"10.1093\/ehjci\/jead184"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Gao Y, Wang HP, Liu MX, Gu H, Yuan XS, Biekan J, et al. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis. European Radiology. 2023; 33: 1982\u20131991.","DOI":"10.1007\/s00330-022-09147-x"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Rubi\u015b PP, Dziewi\u0119cka EM, Bany\u015b P, Urba\u0144czyk-Zawadzka M, Krupi\u0144ski M, Mielnik M, et al. Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy. Scientific Reports. 2021; 11: 24000.","DOI":"10.1038\/s41598-021-03452-z"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Shan R, Gao Y, Wang W, Wang J, Li X, Yuan X, et al. Dark papillary muscles sign is a new prognostic indicator in patients with dilated cardiomyopathy: A multi-center study. International Journal of Cardiology. 2024; 417: 132583.","DOI":"10.1016\/j.ijcard.2024.132583"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Kaolawanich Y, Wendell DC, Kim HW, Chen EL, Chevalier C, Chunharas P, et al. Prognostic Value of Papillary Muscle Scarring in Patients With Dilated Cardiomyopathy. JAMA Cardiology. 2025; 10: 1267\u20131275.","DOI":"10.1001\/jamacardio.2025.3822"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Fong LCW, Lee NHC, Poon JWL, Chin CWL, He B, Luo L, et al. Prognostic value of cardiac magnetic resonance derived global longitudinal strain analysis in patients with ischaemic and non-ischaemic dilated cardiomyopathy: a systematic review and meta-analysis. The International Journal of Cardiovascular Imaging. 2022; 38: 2707\u20132721.","DOI":"10.1007\/s10554-022-02679-9"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Saito N, Kato S, Azuma M, Horita N, Utsunomiya D. Prognostic impact of MRI-derived feature tracking myocardial strain in patients with non-ischaemic dilated cardiomyopathy: a systematic review and meta-analysis. Clinical Radiology. 2024; 79: e702\u2013e714.","DOI":"10.1016\/j.crad.2023.12.029"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Zlibut A, Bietenbeck M, Agoston-Coldea L. CMR-Derived Global Longitudinal Strain and Left Ventricular Torsion as Prognostic Markers in Dilated Cardiomyopathy. Journal of Cardiovascular Development and Disease. 2025; 12: 340.","DOI":"10.3390\/jcdd12090340"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Yang J, Li Y, Hou Y, Luo J, Li Y, Liu S, et al. Incremental Prognostic Value of Cardiac MRI-Based Right-to-Left Ventricular Blood Pool T2 Ratio in Patients With Dilated Cardiomyopathy. Journal of Magnetic Resonance Imaging : JMRI. 2026; 63: 874\u2013888.","DOI":"10.1002\/jmri.70170"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Zhou D, Zhu L, Wu W, Zhuang B, He J, Xu J, et al. A novel cardiac magnetic resonance-based personalized risk stratification model in dilated cardiomyopathy: a prospective study. European Radiology. 2024; 34: 4053\u20134064.","DOI":"10.1007\/s00330-023-10415-7"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Scott PA, Barry J, Roberts PR, Morgan JM. Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis. European Journal of Heart Failure. 2009; 11: 958\u2013966.","DOI":"10.1093\/eurjhf\/hfp123"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Kim H, Cho YK, Jun DH, Nam CW, Han SW, Hur SH, et al. Prognostic implications of the NT-ProBNP level and left atrial size in non-ischemic dilated cardiomyopathy. Circulation Journal : Official Journal of the Japanese Circulation Society. 2008; 72: 1658\u20131665.","DOI":"10.1253\/circj.cj-07-1087"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Tigen K, Karaahmet T, Kahveci G, Tanalp AC, Bitigen A, Fotbolcu H, et al. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm. Heart, Lung & Circulation. 2007; 16: 290\u2013294.","DOI":"10.1016\/j.hlc.2007.02.083"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Wojciechowska C, Romuk E, Nowalany-Kozielska E, Jache\u0107 W. Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated cardiomyopathy patients. Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese. 2017; 58: 350\u2013359.","DOI":"10.1016\/j.hjc.2017.03.006"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Baba Y, Kubo T, Yamanaka S, Hirota T, Tanioka K, Yamasaki N, et al. Clinical significance of high-sensitivity cardiac troponin T in patients with dilated cardiomyopathy. International Heart Journal. 2015; 56: 309\u2013313.","DOI":"10.1536\/ihj.14-335"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Komamura K, Sasaki T, Hanatani A, Kim J, Hashimura K, Ishida Y, et al. Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy. Heart (British Cardiac Society). 2006; 92: 615\u2013618.","DOI":"10.1136\/hrt.2004.043067"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Vergaro G, Del Franco A, Giannoni A, Prontera C, Ripoli A, Barison A, et al. Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy. International Journal of Cardiology. 2015; 184: 96\u2013100.","DOI":"10.1016\/j.ijcard.2015.02.008"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Kayvanpour E, Sedaghat-Hamedani F, Li DT, Miersch T, Weis T, Hoefer I, et al. Prognostic Value of Circulating Fibrosis Biomarkers in Dilated Cardiomyopathy (DCM): Insights into Clinical Outcomes. Biomolecules. 2024; 14: 1137.","DOI":"10.3390\/biom14091137"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Stojkovic S, Kaider A, Koller L, Brekalo M, Wojta J, Diedrich A, et al. GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2. Journal of Cellular and Molecular Medicine. 2018; 22: 2422\u20132429.","DOI":"10.1111\/jcmm.13540"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"May BM, Kochi AN, Magalh\u00e3es APA, Scolari F, Zimerman A, Andrades M, et al. Growth\/differentiation factor-15 (GDF-15) as a predictor of serious arrhythmic events in patients with nonischemic dilated cardiomyopathy. Journal of Electrocardiology. 2022; 70: 19\u201323.","DOI":"10.1016\/j.jelectrocard.2021.10.002"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Ohtsuka T, Nishimura K, Kurata A, Ogimoto A, Okayama H, Higaki J. Serum matrix metalloproteinase-3 as a novel marker for risk stratification of patients with nonischemic dilated cardiomyopathy. Journal of Cardiac Failure. 2007; 13: 752\u2013758.","DOI":"10.1016\/j.cardfail.2007.06.730"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Ampong I. Metabolic and Metabolomics Insights into Dilated Cardiomyopathy. Annals of Nutrition & Metabolism. 2022; 78: 147\u2013155.","DOI":"10.1159\/000524722"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Vignoli A, Fornaro A, Tenori L, Castelli G, Cecconi E, Olivotto I, et al. Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure. Frontiers in Cardiovascular Medicine. 2022; 9: 851905.","DOI":"10.3389\/fcvm.2022.851905"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Laina A, Gatzoulis KA, Soulaidopoulos S, Arsenos P, Doundoulakis I, Tsiachris D, et al. Time to reconsider risk stratification in dilated cardiomyopathy. Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese. 2021; 62: 392\u2013393.","DOI":"10.1016\/j.hjc.2021.03.008"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Rankovic V, Karha J, Passman R, Kadish AH, Goldberger JJ. Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy. The American Journal of Cardiology. 2002; 89: 1072\u20131076.","DOI":"10.1016\/s0002-9149(02)02278-6"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Brilakis ES, Friedman PA, Maounis TN, Rokas SG, Shen WK, Stamatelopoulos SF, et al. Programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and syncope receiving implantable cardioverter-defibrillators: a case series and a systematic review of the literature. International Journal of Cardiology. 2005; 98: 395\u2013401.","DOI":"10.1016\/j.ijcard.2003.12.012"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Gatzoulis KA, Vouliotis AI, Tsiachris D, Salourou M, Archontakis S, Dilaveris P, et al. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation. Circulation. Arrhythmia and Electrophysiology. 2013; 6: 504\u2013512.","DOI":"10.1161\/CIRCEP.113.000216"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Gatzoulis KA, Tsiachris D, Arsenos P, Archontakis S, Dilaveris P, Vouliotis A, et al. Prognostic value of programmed ventricular stimulation for sudden death in selected high risk patients with structural heart disease and preserved systolic function. International Journal of Cardiology. 2014; 176: 1449\u20131451.","DOI":"10.1016\/j.ijcard.2014.08.068"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Mueller KAL, Heck C, Heinzmann D, Schwille J, Klingel K, Kandolf R, et al. Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy. PloS One. 2016; 11: e0167616.","DOI":"10.1371\/journal.pone.0167616"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Doundoulakis I, Soulaidopoulos S, Arsenos P, Dilaveris P, Tsiachris D, Antoniou CK, et al. Unexplained syncope: the importance of the electrophysiology study. Hearts. 2021; 2: 495\u2013504.","DOI":"10.3390\/hearts2040038"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Doundoulakis I, Tsiachris D, Kordalis A, Koliastasis L, Soulaidopoulos S, Arsenos P, et al. Management of Patients With Unexplained Syncope: Derivation and Validation of a Simplified 2-Step Diagnostic Approach. Journal of the American Heart Association. 2023; 12: e031659.","DOI":"10.1161\/JAHA.123.031659"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Dilaveris P, Antoniou CK, Gatzoulis KA. Arrhythmic risk stratification in non-ischemic dilated cardiomyopathy: Where do we stand after DANISH? Trends in Cardiovascular Medicine. 2017; 27: 542\u2013555.","DOI":"10.1016\/j.tcm.2017.06.003"},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Gigli M, Verdonschot JAJ, Garcia-Pavia P, Stolfo D, Monserrat L, Prasad S, et al. Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC. European Journal of Heart Failure. 2025; 27: 2229\u20132243.","DOI":"10.1002\/ejhf.70042"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Kayvanpour E, Sammani A, Sedaghat-Hamedani F, Lehmann DH, Broezel A, Koelemenoglu J, et al. A novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk). International Journal of Cardiology. 2021; 339: 75\u201382.","DOI":"10.1016\/j.ijcard.2021.07.002"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Antonopoulos AS, Xintarakou A, Protonotarios A, Lazaros G, Miliou A, Tsioufis K, et al. Imagenetics for Precision Medicine in Dilated Cardiomyopathy. Circulation. Genomic and Precision Medicine. 2024; 17: e004301.","DOI":"10.1161\/CIRCGEN.123.004301"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Mirelis JG, Escobar-Lopez L, Ochoa JP, Espinosa M\u00c1, Villacorta E, Navarro M, et al. Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy. European Journal of Heart Failure. 2022; 24: 1183\u20131196.","DOI":"10.1002\/ejhf.2514"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Gasperetti A, Carrick RT, Costa S, Compagnucci P, Bosman LP, Chivulescu M, et al. Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study. Circulation. 2022; 146: 1434\u20131443.","DOI":"10.1161\/CIRCULATIONAHA.122.060866"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"Verdonschot JAJ, van Spaendonck-Zwarts KY, Hellebrekers DMEI, Asselbergs FW, Behr ER, Charron P, et al. Genetic counselling implementation in dilated cardiomyopathy: A clinical consensus statement of the Heart Failure Association of the ESC, the ESC Working Group on Myocardial and Pericardial Diseases, and the ESC Council on Cardiovascular Genomics. European Heart Journal. 2026; ehag159.","DOI":"10.1093\/eurheartj\/ehag159"},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"Verstraelen TE, van Lint FHM, Bosman LP, de Brouwer R, Proost VM, Abeln BGS, et al. Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction. European Heart Journal. 2021; 42: 2842\u20132850.","DOI":"10.1093\/eurheartj\/ehab294"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Kramarenko DR, Jurgens SJ, Pinto YM, Bezzina CR, Amin AS. Polygenic Risk Scores in Dilated Cardiomyopathy: Towards the Future. Current Cardiology Reports. 2025; 27: 87.","DOI":"10.1007\/s11886-025-02239-2"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"Antoniou CK, Karampinos K, Tsiachris D, Kordalis A, Arsenos P, Doundoulakis I, et al. Current trends in virtual electrophysiology use for risk stratification and treatment of ventricular arrhythmias. Frontiers in Cardiovascular Medicine. 2025; 12: 1709175.","DOI":"10.3389\/fcvm.2025.1709175"},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"Balaban G, Halliday BP, Mendonca Costa C, Bai W, Porter B, Rinaldi CA, et al. Fibrosis Microstructure Modulates Reentry in Non-ischemic Dilated Cardiomyopathy: Insights From Imaged Guided 2D Computational Modeling. Frontiers in Physiology. 2018; 9: 1832.","DOI":"10.3389\/fphys.2018.01832"},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"Shu S, Hong Z, Peng Q, Zhou X, Zhang T, Wang J, et al. A machine-learning-based method to predict adverse events in patients with dilated cardiomyopathy and severely reduced ejection fractions. The British Journal of Radiology. 2021; 94: 20210259.","DOI":"10.1259\/bjr.20210259"},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"Corian\u00f2 M, Lanera C, De Michieli L, Perazzolo Marra M, Iliceto S, Gregori D, et al. Deep learning-based prediction of major arrhythmic events in dilated cardiomyopathy: A proof of concept study. PloS One. 2024; 19: e0297793.","DOI":"10.1371\/journal.pone.0297793"},{"key":"ref110","doi-asserted-by":"publisher","unstructured":"Kolk MZH, Ruip\u00e9rez-Campillo S, Allaart CP, Wilde AAM, Knops RE, Narayan SM, et al. Multimodal explainable artificial intelligence identifies patients with non-ischaemic cardiomyopathy at risk of lethal ventricular arrhythmias. Scientific Reports. 2024; 14: 14889.","DOI":"10.1038\/s41598-024-65357-x"},{"key":"ref111","doi-asserted-by":"publisher","unstructured":"Sammani A, van de Leur RR, Henkens MTHM, Meine M, Loh P, Hassink RJ, et al. Life-threatening ventricular arrhythmia prediction in patients with dilated cardiomyopathy using explainable electrocardiogram-based deep neural networks. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 2022; 24: 1645\u20131654.","DOI":"10.1093\/europace\/euac054"},{"key":"ref112","doi-asserted-by":"publisher","unstructured":"Selvanayagam JB, Hartshorne T, Billot L, Grover S, Hillis GS, Jung W, et al. Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial. Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc. 2017; 22: e12420.","DOI":"10.1111\/anec.12420"},{"key":"ref113","doi-asserted-by":"publisher","unstructured":"Flett A, Cebula A, Nicholas Z, Adam R, Ewings S, Prasad S, et al. Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure). American Heart Journal. 2023; 266: 149\u2013158.","DOI":"10.1016\/j.ahj.2023.09.008"},{"key":"ref114","doi-asserted-by":"publisher","unstructured":"Gatzoulis KA, Dilaveris P, Arsenos P, Tsiachris D, Antoniou CK, Sideris S, et al. Arrhythmic risk stratification in nonischemic dilated cardiomyopathy: The ReCONSIDER study design - A two-step, multifactorial, electrophysiology-inclusive approach. Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese. 2021; 62: 169\u2013172.","DOI":"10.1016\/j.hjc.2020.03.008"},{"key":"ref115","doi-asserted-by":"publisher","unstructured":"Demir E, K\u00f6se MR, \u015eim\u015fek E, Orman MN, Zoghi M, G\u00fcrg\u00fcn C, et al. Comparative analysis of implantable cardioverter-defibrillator efficacy in ischemic and non-ischemic cardiomyopathy in patients with heart failure. Scientific Reports. 2025; 15: 24631.","DOI":"10.1038\/s41598-025-09074-z"},{"key":"ref116","doi-asserted-by":"publisher","unstructured":"Butt JH, Doi SN, Thune JJ, Nielsen JC, Videb\u00e6k L, Yafasova A, et al. Long-Term Effect of ICDs in Nonischemic Heart Failure With Reduced Ejection Fraction: Extended Follow-Up Analysis of DANISH. Journal of the American College of Cardiology. 2025; 86: 2402\u20132414.","DOI":"10.1016\/j.jacc.2025.08.089"},{"key":"ref117","doi-asserted-by":"publisher","unstructured":"Xenogiannis I, Gatzoulis KA, Flevari P, Ikonomidis I, Iliodromitis E, Trachanas K, et al. Temporal changes of noninvasive electrocardiographic risk factors for sudden cardiac death in post-myocardial infarction patients with preserved ejection fraction: Insights from the PRESERVE-EF study. Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc. 2020; 25: e12701.","DOI":"10.1111\/anec.12701"},{"key":"ref118","doi-asserted-by":"publisher","unstructured":"Lamounier J\u00fanior A, Ferrari F, Max R, Ritt LEF, Stein R. Importance of Genetic Testing in Dilated Cardiomyopathy: Applications and Challenges in Clinical Practice. Arquivos Brasileiros De Cardiologia. 2019; 113: 274\u2013281.","DOI":"10.5935\/abc.20190144"},{"key":"ref119","doi-asserted-by":"publisher","unstructured":"Xintarakou A, Kariki O, Doundoulakis I, Arsenos P, Soulaidopoulos S, Laina A, et al. The Role of Genetics in Risk Stratification Strategy of Dilated Cardiomyopathy. Reviews in Cardiovascular Medicine. 2022; 23: 305.","DOI":"10.31083\/j.rcm2309305"},{"key":"ref120","doi-asserted-by":"publisher","unstructured":"Stroeks SLVM, Wang P, Merlo M, Muller S, Paldino A, Mora-Ayestaran N, et al. Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy. European Journal of Heart Failure. 2025; 27: 3205\u20133218.","DOI":"10.1002\/ejhf.70040"},{"key":"ref121","doi-asserted-by":"publisher","unstructured":"Milaras N, Pamporis K, Gatzoulis K, Karakasis P, Dourvas P, Ktenopoulos N, et al. The Nondilated Left Ventricular Cardiomyopathy Phenotype: Arrhythmic Prognosis and Differences With Dilated Cardiomyopathy. The American Journal of Cardiology. 2026; 262: 35\u201344.","DOI":"10.1016\/j.amjcard.2025.12.017"},{"key":"ref122","doi-asserted-by":"publisher","unstructured":"Milaras N, Pamporis K, Gatzoulis KA, Karakasis P, Kostakis P, Sotiriou Z, et al. Temporal Variability of ECG Risk Markers and Clinical Outcomes in Non-Dilated Left Ventricular Cardiomyopathy. Journal of Clinical Medicine. 2026; 15: 402.","DOI":"10.3390\/jcm15020402"},{"key":"ref123","doi-asserted-by":"publisher","unstructured":"Peretto G, Merlo M, Ambrosi A, Bacigalupi E, Villatore A, Molinari L, et al. Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score. European Heart Journal. 2026; 47: 94\u2013106.","DOI":"10.1093\/eurheartj\/ehaf477"},{"key":"ref124","doi-asserted-by":"publisher","unstructured":"Tsiachris D, Botis M, Doundoulakis I, Bartsioka LI, Tsioufis P, Kordalis A, et al. Electrocardiographic Characteristics, Identification, and Management of Frequent Premature Ventricular Contractions. Diagnostics (Basel, Switzerland). 2023; 13: 3094.","DOI":"10.3390\/diagnostics13193094"},{"key":"ref125","unstructured":"Gatzoulis KA, Aggeli C, Dimitroglou Y, Archontakis S, Arsenos P, Vlaseros I, et al. Which is the Best Risk Stratification Approach for Patients with Ventricular Arrhythmias in the Absence of Apparent Structural Heart Disease? Annals of Cardiology and Vascular Medicine. 2020; 3: 1026."},{"key":"ref126","doi-asserted-by":"publisher","unstructured":"Laina A, Antoniou CK, Tsiachris D, Kordalis A, Arsenos P, Doundoulakis I, et al. CRT-D or CRT-P: When There Is a Dilemma and How to Solve It. Journal of Clinical Medicine. 2025; 14: 6933.","DOI":"10.3390\/jcm14196933"},{"key":"ref127","doi-asserted-by":"publisher","unstructured":"Archontakis S, Sideris K, Laina A, Arsenos P, Paraskevopoulou D, Tyrovola D, et al. His bundle pacing: A promising alternative strategy for anti-bradycardic pacing - report of a single-center experience. Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese. 2022; 64: 77\u201386.","DOI":"10.1016\/j.hjc.2021.10.005"},{"key":"ref128","doi-asserted-by":"publisher","unstructured":"Leventopoulos G, Travlos CK, Anagnostopoulou V, Patrinos P, Papageorgiou A, Perperis A, et al. Clinical Outcomes of Left Bundle Branch Area Pacing Compared with Biventricular Pacing in Patients with Heart Failure Requiring Cardiac Resynchronization Therapy: Systematic Review and Meta-Analysis. Reviews in Cardiovascular Medicine. 2023; 24: 312.","DOI":"10.31083\/j.rcm2411312"},{"key":"ref129","doi-asserted-by":"publisher","unstructured":"Leventopoulos G, Patrinos P, Papageorgiou A, Katechis S, Perperis A, Travlos C, et al. Left bundle branch area pacing versus conventional pacing in patients with advanced atrioventricular conduction abnormalities: a prospective cohort study. Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese. 2025; 84: 32\u201342.","DOI":"10.1016\/j.hjc.2024.03.005"},{"key":"ref130","doi-asserted-by":"publisher","unstructured":"Milaras N, Oikonomou E, Letsas KP, Ktenopoulos N, Xydonas S, Korantzopoulos P, et al. Real-World Efficacy and Safety of the Subcutaneous Implantable Cardioverter Defibrillator: Insights from the GASP Registry. Biomedicines. 2025; 13: 1510.","DOI":"10.3390\/biomedicines13071510"},{"key":"ref131","doi-asserted-by":"publisher","unstructured":"Markman TM, Callahan TD. The extravascular ICD: Evolving paradigms in sudden death prevention. Heart Rhythm. 2026; 23: 186\u2013193.","DOI":"10.1016\/j.hrthm.2025.09.038"},{"key":"ref132","doi-asserted-by":"publisher","unstructured":"Andersen LW, Holmberg MJ, Krijkamp E, Stankovic N, Meilandt C, Vallentin MF, et al. Effectiveness and Cost-Effectiveness of Automated External Defibrillators in Private Homes: A Report From the Cardiac Arrest Registry to Enhance Survival. JAMA Internal Medicine. 2026; 186: 37\u201343.","DOI":"10.1001\/jamainternmed.2025.6123"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/7\/10.31083\/RCM49889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:33:12Z","timestamp":1785407592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/7\/10.31083\/RCM49889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":132,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1530-6550(26)03249-0"],"URL":"https:\/\/doi.org\/10.31083\/rcm49889","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"article-number":"49889"}}